期刊文献+

ARHGAP4在结直肠癌中的表达及临床意义 被引量:3

Expression and clinical significance of ARHGAP4 in colorectal cancer
暂未订购
导出
摘要 目的:研究ARHGAP4基因在结直肠癌中的表达及临床意义。方法:采用RT-PCR、Western blot及免疫组化分析ARHGAP4基因在结直肠癌组织及细胞系中的表达水平,分析其表达与临床病理特征的相关性。结果:ARHGAP基因在结直肠癌组织及结直肠癌细胞系中的表达较癌旁正常组织及正常结肠上皮细胞明显升高。其蛋白表达水平与肿瘤的T分类,N分类,远处转移及生存时间密切相关(P<0.05)。结论:ARHGAP4过表达可能促进结直肠癌的发生、发展,具有作为结直肠癌预后判断标记物的潜能。 Objective To study the expression and clinical significance of ARHGAP4 in colorectal cancer Method Real- time PCR, Western blot and immunocytochemistry were used to detect the expression of ARHGAP4 in colorectal cancer tissues and cell lines, and the correlation between its expression and clinical features of patients was analyzed Results ARHGAP4 is overexpressed in colorectal cancer tissues and cell lines and its overexpression is correlated with T stage, N stage, clinical stage, and metastasis. Conclusion ARHGAP4 may promote the progression of colorectal cancer, and have the potential to be a novel prognosis marker .
出处 《实用医学杂志》 CAS 北大核心 2017年第5期705-708,共4页 The Journal of Practical Medicine
基金 广东省科技厅产学研协同创新成果转化项目(编号:2016B090918130)
关键词 结直肠肿瘤 ARHGAP4 临床意义 Colorectal cancer ARHGAP4
  • 相关文献

参考文献2

二级参考文献29

  • 1Shin HR, Jung KW, Won Y J, et al. National cancer incidence for the year 2002 in Korea [J]. Cancer Res Treat, 2007,39(4) : 139-149.
  • 2Yeoh KG. How do we improve outcomes for gastric cancer [J]? J Gastroenterol Hepatol, 2007,22 (7) : 970-972.
  • 3Greene FL, Page D, Morrow M. AJCC Cancer Staging Manual[M]. 6th ed.New York:Springer, 2002: 136-155.
  • 4Espasito I, Kayed H, Keleg S, et al. Tumor-suppressor function of SPABC-like protein 1/Herin in pancreatic cancer [J]. Neoplasia, 2007,9 ( 1 ) : 8-17.
  • 5Hurley PJ, Marehionni L, Simons BW, et al. Secreted protein, acidic and rich in cysteine-like I (SPARCLI) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome [J]. Proc Natl Acad Sei USA, 2012,109(37):14977- 14982.
  • 6Xiang Y, Qiu Q, Jiang M, et al. SPARCL1 suppresses metastasis in prostate cancer [J]. Mol Oncol, 2013,7(6) : 1019- 1030.
  • 7Ceo F, Wang K, Zhu R, et al. Clinicnpathological significance of reduced SPARCL1 expression in human breast cancer [J]. Asian Pac J Cancer Prey, 2013,14( 1 ) : 195-200.
  • 8Zaravinos A, Lambrou GI, Boulalas I, et al. Identification of common differentially expressed genes in urinary bladder cancer [J]. Plos One, 2011,6(4) :e18135.
  • 9Esposito I, Kayed H, Keleg S, et al. Tumor-suppressor function of SPARC-Iike protein 1/Herin in pancreatic cancer [J].Neoplasia, 2007,9 ( 1 ) : 8-17.
  • 10Lau CP, Poon RT, Cheung ST, et al. SPARC and Hevin expression correlate with 'tumour angiogenesis in hepatocellular carcinoma [J]. J Pathol, 2006,210(4):459-468.

共引文献2

同被引文献14

引证文献3

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部